Another study using GKT137831, a dual inhibitor of NOX1/4 in streptozotocin induced diabetic ApoEKO mouse model showed protection against atherosclerosis by reducing aortic plaque formation and inflammation via reduction in ROS formation [46]. The gene discussed is NOX1; the disease is atherosclerosis.